Federal health officials will meet this summer to consider easing restrictions on a controversial group of drugs popular with ...
Peptide-based substances are largely unproven and risky, experts say, but they’re gaining popularity among influencers and ...
The Food and Drug Administration will announce on Monday that it has sent over 2,200 letters pressing drug manufacturers, ...
Over the last 30 years, scientists have experimented with ways to harness plant biology to create medications, or even deliver vaccines to animals and humans — but the science has moved away from ...
President Donald Trump’s new pick to lead the US Centers for Disease Control and Prevention is a public health veteran who ...
The vice president is also the finance chair of the Republican National Committee, allowing him to court donors who could ...
3don MSNOpinion
Massive eye drop recall reflects ongoing issues with manufacturing and FDA inspection
A California company has recalled more than 3.1 million bottles of lubricating eye drops because it had not properly tested – ...
FDA moves shaping drug development and oversight include new gene therapy guidance, clinical trial transparency efforts, and recent drug approvals.
The Trump administration’s MAHA agenda is accelerating food reformulation, but reliance on informal policy signals is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results